Friday - December 12, 2025
FDA Issues Warning Letter to Catalent Indiana
December 12, 2025
WASHINGTON, Dec. 12 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Catalent Indiana LLC from the Office of Manufacturing Quality:

* * *

Recipient: Mr. Maziar Doustdar, President and Chief Executive Officer, Catalent Indiana, LLC, Novo Alle 1, 2880 Bagsvaerd Hovedstaden, Denmark, mmd@novonordisk.com

Issuing Office: Office of Manufacturing Quality, United States

Warning Lett . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products